Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
Description One of the priorities of project 2023-T1/BIO28997 “Development of biofactory plants for the sustainable production of high-value compounds” is the implementation of the objective “To generate
-
of diagnostic tests for primary ciliary dyskinesia and in the establishment of cell cultures for the development of new therapies. Where to apply Website https://jobs.vhir.org/jobs/7351096-postdoctoral-researcher
-
activities. Where to apply Website https://talent.irta.cat/en/jobs/7406314-researcher-in-design-and-development-of… Requirements Research FieldOtherEducation LevelPhD or equivalent Skills/Qualifications
-
d'Arqueologia Clàssica (ICAC) is a public research institution created by the Generalitat de Catalunya and the Universitat Rovira i Virgili. ICAC aims to research, train and disseminate the protohistoric
-
to the publication of the call for applications: https://seu.ub.edu/ofertaPublicaCategoriaPublic/listPublicacionsAmbCategoria?categoria.id=855899 Where to apply Website http://www.ub.edu/caiac/solBeca?idConvocatoria
-
2DFERROPLEX, contributing to the development of all-optical neuromorphic components based on two-dimensional ferroelectric heterostructures. Key responsibilities include: Development, preparation, and
-
environment. The Functional Optoelectronic NanoMaterials group at ICFO, led by ICREA Prof. Gerasimos Konstantatos, is looking for outstanding, creative and highly motivated researchers to develop highly
-
develop new knowledge and innovations at the interface of biodiversity, environmental health and biotechnology. The Institutes The Andorra Recerca + Innovació (ARI) is the national research and innovation
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
inhouse developed long-acting GLP-1 receptor agonist, Efsubaglutide alfa , has achieved regulatory approval and market access in China representing a major milestone in biologics innovation originating from